Probiotec Limited (AU:PBP) has released an update.
Probiotec Limited has announced the advancement of its acquisition by PT Pyridam Farma TBK’s subsidiary, Pyridam Sub, with the Australian Foreign Investment Review Board’s approval now secured. The implementation of the acquisition scheme, which awaits Probiotec shareholder and final court approvals, is recommended by Probiotec’s CEO and Independent Board Committee. Shareholders are advised to review the Scheme Booklet thoroughly and consult professional advisers for any inquiries regarding the arrangement.
For further insights into AU:PBP stock, check out TipRanks’ Stock Analysis page.
